Clinical Pdx Studies

Champions Oncology

18/06/2018 13:47

Champions Biotechnology  Inc  CSBR.O :
    * CHAMPIONS ONCOLOGY PARTNERS WITH PUMA BIOTECHNOLOGY AND
NSABP
FOUNDATION ON METASTATIC BREAST AND COLON CANCER CO-CLINICAL PDX
STUDIES
    * CHAMPIONS BIOTECHNOLOGY - FIRST TRIAL IS PHASE II STUDY OF
TRASTUZUMAB EMTANSINE WITH NERATINIB IN WOMEN WITH METASTATIC
HER2-POSITIVE BREAST CANCER
    * CHAMPIONS BIOTECHNOLOGY- SECOND TRIAL IS FOR
NERATINIB+TRASTUZUMAB/NERATINIB +CETUXIMAB IN PATIENTS WITH
"QUADRUPLE WILD-TYPE" METASTATIC COLORECTAL CANCER

Source text for Eikon:  ID:nPnx4qfha 
Further company coverage:  CSBR.O